biosynthetic studies. To obtain maximal labeling of collagenous protein, the growth media were replaced with 10 ml of the Dulbecco-Vogt medium lacking glycine, lysine, glutamate, and serum but supplemented with ascorbic acid (50 ug/ml) and ,3-aminopropionitrile (50 Ag/ml) (10). Twenty microcuries each of [U-'4C]glycine, [U-14C]proline, and [U-14C]-lysine were added to each flask. Usually cells were exposed to label for 24 hr, except in the studies designed to measure the extractability and synthetic rates of collagen where labeling was carried out for 96 hr without ,3-aminopropionitrile.
Osteogenesis imperfecta (OI) is a heritable disorder of connective tissue characterized by fragile bones, but also including opalescent teeth, thin skin, and blue sclera (1) . Although the disease is genetically and clinically heterogeneous, two main clinical varieties are recognized according to the onset and severity of symptoms. Defects in the tissues of the congenital form of the disease may prove lethal at birth while patients with the tarda form exhibit milder symptoms, most notably increased fractures of bones. Histological studies of tissues from patients with OI point toward an abnormality in collagen (2) (3) (4) . The irregular pattern of collagen fibrils normally present in the skeletal tissues and cornea of fetuses and newborns persists until a much older age in patients with 01. Recent studies have established the existence of several chemically and genetically distinct collagens. Type I collagen has the chain composition [a1 (I) ]2a2 and is the major collagen species in mature skin, bone, and tendon (5) . Skin, aorta, and certain other tissues also contain various amounts of type III collagen, [al (III)13 (6) (7) (8) . Type III collagen may account for half or more of the collagen in fetal skin, but less is found in the skin of older individuals. Type I collagen is the only collagen known to occur in mature bone (9) . We biosynthetic studies. To obtain maximal labeling of collagenous protein, the growth media were replaced with 10 ml of the Dulbecco-Vogt medium lacking glycine, lysine, glutamate, and serum but supplemented with ascorbic acid (50 ug/ml) and ,3-aminopropionitrile (50 Ag/ml) (10 In other experiments, medium and cell layer were combined, carrier collagen (20 mg) was added, and these samples were incubated with pepsin under conditions (10) (14) .
Preparation of Standards. Type I collagen was extracted with acid from rat and human skin and purified by a standard procedure (14) . Type III collagen was solubilized by limited digestion of human skin with pepsin, as described by Epstein (7), Chung and Miller (8) , and Trelstad (15) . Type III collagen was separated from type I collagen by an initial precipitation with 1.5 M NaCl and purified further by chromatography on CM-cellulose (7, 8, 15) . In some studies labeled components, as well as authentic al(I), a2, and al(III), were digested with CNBr after reduction and alkylation. Peptides produced by CNBr cleavage were partially resolved by chromatography on CM-cellulose (6) or by electrophoresis on 7.5% sodium dodecyl sulfate-acrylamide gels (16) . The radioactivity in labeled extracts, column effluents, and gel fractions was assayed by standard techniques of scintillation spectrometry. RESULTS Rates of Collagen Synthesis. In our initial studies the proportions of collagenous to noncollagenous proteins synthesized by an 01 cell strain (ATCC no. 1262, baby girl D), and an agematched control skin (no. 1146) were estimated by two methods. In one study, cells were labeled with radioactive amino acids for 24 hr, and the radioactivity incorporated into peptide-bound hydroxyproline, proline, hydroxylysine, and lysine in dialyzed aliquots of media, into extracts of the cell layer, and into the insoluble residues, was determined with an amino-acid analyzer. In the second experiment (done without 0-aminopropionitrile), we used collagenase digestion to measure the collagen content. Both studies showed that similar amounts of collagen were synthesized by the 01 and control strains. In a labeling experiment without fl-aminopropio- were similar in these two strains and resembled those values previously published (10) .
Characterization of Collagen Precursors Secreted by 01 and Control Cells. Subsequent studies were directed toward characterizing the collagenous proteins made by the cell strains. It has been shown that most of the collagenous protein found in the medium is soluble precursors of type I and type III collagens, which can be separated by chromatography on DEAE-cellulose. By this method radioactive protein was eluted by the gradient in three regions labeled A, B, and C in Fig. 1 . Peak A contains primarily type I collagen. Peak B contains precursors of type I collagen, while peak C contains precursors of type III collagen (17) . The identification of the three fractions A, B, and C from 01 strain no. 1262 was confirmed by digesting the proteins with CNBr and chromatographing the resulting peptides on CM-cellulose. Fractions A and B produced the profile of peptides expected from type I collagen, while fraction C produced the profile of peptides found in type III collagen. Type I procollagen was the most prominent constituent in control medium, whereas the proportions of type I and type III procollagen were markedly different in the OI strain no. 1262. When the same amount of radioactive protein was applied to the column, more collagenasedigestible material was recovered in the region identified as fraction C in Fig. 1 (10, 18) . This procedure converts precursor forms to collagen-like molecules. The components of this digest were denatured and resolved by chromatography on CM-cellulose. In addition to the material not bound to the column, four radioactive, collagenase-susceptible fractions were recovered (Fig. 2) . Two peaks were identified as a 1 (1) (Fig. 3) Recent studies (17, 20) have shown that cell strains from skin synthesize two different collagens, type I and type III. The precursor forms of these collagens are readily resolved on DEAE-cellulose and the denatured proteins on CM-cellulose.
We used these two methods to estimate the ratio in which the two types of collagens are synthesized by cells in culture and have found that control cell strains synthesize predominantly type I collagenous protein (17) . Cells from patients with osteogenesis imperfecta fell into three groups.
In the first group, type III collagen accounted for a greater proportion of the total accumulated in the cultures of OI strain no. 1262 as judged by the proportion of precursor forms in the medium and the proportion of al(III) to al(I) chains isolated after pepsin digestion of medium and cell layer.
In the second group, the proportion of type III collagen synthesized by strains 1280, 1251, and 1248 was elevated as judged by the CM-cellulose assay, but the profiles of proteins on DEAE-cellulose appeared normal. It should be noted that these procedures measure different parameters. Precursors of type I and III collagens present in the media are estimated after chromatography on DEAE-cellulose. The assay of al (I) and al (III) chains by CM-cellulose involves an initial treatment with pepsin to convert precursor forms to collagen and also to solubilize precipitated collagens. It is likely that there is some loss of a2 during this procedure, since the ratio of a1 (I) to a2 is greater than 2. If the OI strains 1280, 1251, and 1248 produced type I collagen containing an amino-acid substitution weakening the helical structure of collagen, degradation of type I collagen could alter the apparent ratio of al (I) to al (III). Alternatively, differences in the extent of conversion of procollagens type I and III in these cell strains might explain the discrepancy. The third group is comprised of cell strains from several patients with osteogenesis imperfecta that showed no difference in the proportion of type I and III collagens by either test. Such diversity of findings in the cells from these patients is neither unexpected nor without precedence. Patients grouped under the diagnosis of osteogenesis imperfecta are genetically and clinically heterogeneous (1), and it would not be surprising that different molecular defects would give rise to similar clinical findings. This has been the case with patients with the Ehlers-Danlos'syndrome (21) (22) (23) .
While the alterations noted in OI strain no. 1262 could result from differences in the synthesis of either protein, we favor the interpretation that the synthesis of type I collagen is reduced since bone is largely made of type I collagen and is more affected than skin, which contains both types of collagen. Decreased synthesis of type I collagen in strain no. 1262 would lessen tissue contents and explain the generalized tissue fragility.
